On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Marcela V. Maus

ResearcherPublications, citations & collaboration network

Marcela V. Maus is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Marcela V. Maus have?

ScholarIQindexed works

Marcela V. Maus has 512 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Marcela V. Maus have?

ScholarIQcitation count

Marcela V. Maus has 33,533 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Marcela V. Maus?

ScholarIQh-index

Marcela V. Maus has an h-index of 83 in OpenAlex.

What is the i10-index of Marcela V. Maus?

ScholarIQi10-index

Marcela V. Maus has an i10-index of 186 in OpenAlex.

What is the ORCID of Marcela V. Maus?

ScholarIQorcid

The ORCID for Marcela V. Maus is on the source record.

What is the OpenAlex record for Marcela V. Maus?

ScholarIQopenalex

The OpenAlex for Marcela V. Maus is on the source record.

What are the most-cited papers on Marcela V. Maus?

ScholarIQmost cited works
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje, Jesús G. Berdeja, Yi Lin, David S. Siegel, Sundar Jagannath, Deepu Madduri, Michaela Liedtke, Jacalyn Rosenblatt, Marcela V. Maus, Ashley Turka, Lyh-Ping Lam, Richard A. Morgan, Kevin M. Friedman, Monica Massaro, Julie Wang, Greg Russotti, Zhihong Yang, Timothy Campbell, Kristen Hege, Fabio Petrocca, M. Travis Quigley, Nikhil C. Munshi, James N. Kochenderfer
New England Journal of Medicine. 20191,752 CitationsOPEN ACCESS
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
Alfred L. Garfall, Marcela V. Maus, Wei‐Ting Hwang, Simon F. Lacey, Yolanda D. Mahnke, J. Joseph Melenhorst, Zhaohui Zheng, Dan T. Vogl, Adam D. Cohen, Brendan M. Weiss, Karen Dengel, Naseem Kerr, Adam Bagg, Bruce L. Levine, Carl H. June, Edward A. Stadtmauer
New England Journal of Medicine. 2015639 CitationsOPEN ACCESS
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial
Matthew J. Frigault, Jörg Dietrich, Kathleen Gallagher, Mark Roschewski, Justin T. Jordan, Deborah Forst, Scott R. Plotkin, Daniella Cook, Keagan S. Casey, Kevin Lindell, Gabriel D. Depinho, Katelin Katsis, Eva L. Elder, Mark B. Leick, Bryan D. Choi, Nora Horick, Frederic I. Preffer, Meredith Saylor, Steven L. McAfee, Paul V. O’Donnell, Thomas R. Spitzer, Bimalangshu R. Dey, Zachariah DeFilipp, Areej El‐Jawahri, Tracy T. Batchelor, Marcela V. Maus, Yi‐Bin Chen
Blood. 2022142 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account